Hypoxia-inducible factor-1 alpha (HIF-1α), for instance, is a key transcriptional regulator in adaptive response to hypoxic tumor microenvironment, which represents an interesting cancer drug target [37, 38]. This evidence concerns the gene HIF1A and neoplasm.